Home
Back| Recommended Indications for Eradication of Helicobacter Pylori and Strength of Recommendations | ||
|---|---|---|
| Helicobacter Pylori Positive | Strongly Recommended | Recommended |
| Peptic Ulcer (regardless of activity or history of complications) | √ | |
| Gastric Mucosa-associated Lymphoid Tissue Lymphoma | √ | |
| Chronic Gastritis with Dyspeptic Symptoms | √ | |
| Chronic Gastritis with Gastric Mucosal Atrophy or Erosion | √ | |
| Early Gastric Tumor with Endoscopic Resection or Surgical Subtotal Gastrectomy | √ | |
| Long-term Use of Proton Pump Inhibitors | √ | |
| Family History of Gastric Cancer | √ | |
| Planned Long-term Use of Non-Steroidal Anti-Inflammatory Drugs (including low-dose Aspirin) | √ | |
| Iron Deficiency Anemia of Unknown Cause | √ | |
| Idiopathic Thrombocytopenic Purpura | √ | |
| Other Helicobacter Pylori-Related Diseases (such as Lymphocytic Gastritis, Hyperplastic Gastric Polyps, Ménétrier Disease) | √ | |
| Confirmed Helicobacter Pylori Infection | √ | |
Explanation
"Treat all Hp-positive individuals, but do not perform testing if treatment is not intended." This is a good practice point proposed in the "Clinical Guidelines for Hp Infection in Developing Countries" established by the World Gastroenterology Organization. Therefore, Hp testing should be based on eradication indications and should not be arbitrarily expanded to other subjects.
